Abstracts: Poster Presentation
- A Pooled Analysis of the Effects of Desvenlafaxine Succinate on Symptoms of Anxiety in Patients with Major Depressive Disorder
- Assessing Depression in Acute Coronary Syndrome Patients
- Evaluation of the Efficacy and Safety of Desvenlafaxine 50 and 100 mg/d in Patients With Major Depressive Disorder: Results From 2 Placebo-Controlled Studies
- The Kava Anxiety Depression Spectrum Study (KADSS): A randomized, placebo-controlled, cross-over trial using an aqueous extract of Piper methysticum
4 abstracts